ArticleBlood2022

Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL.

Kensuke Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.